BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1
36522 results:

  • 1. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
    Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
    World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway.
    Zhang T; Zhang X; Fei Y; Lu J; Zhou D; Zhang L; Fan S; Zhou J; Liang C; Su Y
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38818827
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High-frame-rate contrast-enhanced ultrasound to differentiate between clear cell renal cell carcinoma and angiomyolipoma.
    Wang J; Shi J; Gao L; Hu W; Chen M; Zhang W
    BMC Cancer; 2024 May; 24(1):659. PubMed ID: 38816725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pulmonary lesion after surgery for renal cancer: progression or new primary?
    Cignoli D; Bandiera A; Rosiello G; Castorina R; Re C; Cei F; Musso G; Belladelli F; Freschi M; Lucianò R; Raggi D; Negri G; Necchi A; Salonia A; Montorsi F; Larcher A; Capitanio U
    World J Urol; 2024 May; 42(1):361. PubMed ID: 38814376
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma.
    Yamashita S; Hamamoto S; Furukawa J; Fujita K; Takahashi M; Miyake M; Ito N; Iwamoto H; Kohjimoto Y; Hara I
    Sci Rep; 2024 May; 14(1):12398. PubMed ID: 38811687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Mehra R; Nallandhighal S; Cotta B; Knuth Z; Su F; Kasputis A; Zhang Y; Wang R; Cao X; Udager AM; Dhanasekaran SM; Cieslik MP; Morgan TM; Salami SS
    JCO Precis Oncol; 2024 May; 8():e2300565. PubMed ID: 38810179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway.
    Zhang ZY; Xu JH; Zhang JL; Lin YX; Ou-Yang J
    BMC Cancer; 2024 May; 24(1):650. PubMed ID: 38802739
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association between elevated preoperative red cell distribution width and mortality after brain tumor craniotomy.
    Wang P; Zhang Y; Xu W; Zheng Y; Jia L; He J; He M; Chen L; Hao P; Xiao Y; Peng L; Chong W; Hai Y; You C; Fang F
    Neurosurg Rev; 2024 May; 47(1):237. PubMed ID: 38802619
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is endothelin targeting finally ready for prime time?
    Schinzari F; Tesauro M; Cardillo C
    Clin Sci (Lond); 2024 Jun; 138(11):635-644. PubMed ID: 38785409
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro.
    Gbelcová H; Rimpelová S; Jariabková A; Macášek P; Priščáková P; Ruml T; Šáchová J; Kubovčiak J; Kolář M; Vítek L
    Sci Rep; 2024 May; 14(1):11830. PubMed ID: 38782983
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. kidney transplantation in patients with tuberous sclerosis complex.
    Goedken AM; Ismail WW; Barrett LDG; Harshman LA
    Pediatr Transplant; 2024 Jun; 28(4):e14765. PubMed ID: 38778713
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study.
    Hai L; Liu S; Ma L; Ding X; Bai X; Luo X
    Technol Cancer Res Treat; 2024; 23():15330338241250315. PubMed ID: 38773767
    [No Abstract]    [Full Text] [Related]  

  • 13. The effect of unusual presentation on delayed diagnosis of prostate cancer: a case series.
    Oyortey MA; Adanu KK; Ali MA
    J Med Case Rep; 2024 May; 18(1):256. PubMed ID: 38773554
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
    Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
    Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
    Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Three-dimensional virtual model for robot-assisted partial nephrectomy: a propensity-score matching analysis with a contemporary control group.
    Grosso AA; Di Maida F; Lambertini L; Cadenar A; Coco S; Ciaralli E; Salamone V; Vittori G; Tuccio A; Mari A; Ludovico GM; Minervini A
    World J Urol; 2024 May; 42(1):338. PubMed ID: 38767673
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?
    Ilhan Y; Onder AH; Ozbay MF; Karakaya G; Sezgin Goksu S; Ozturk B; Coskun HS
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3403-3413. PubMed ID: 38766796
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue.
    Connaughton M; Dabagh M
    IEEE J Transl Eng Health Med; 2024; 12():413-434. PubMed ID: 38765886
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CircSCNN1A inhibits the proliferation, migration and invasion of renal cell carcinoma cells by decreasing CLDN8 expression through miR-590-5p.
    Guo T; Xiong W; Liu C; Zhu L; Xie L
    Genesis; 2024 Jun; 62(3):e23599. PubMed ID: 38764323
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1827.